lobbying_activities: 1268827

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1268827	2c69d66f-3f98-40b1-9292-5bc810218a8e	Q2	FABIANI & COMPANY	72576	ZIOPHARM ONCOLOGY, INC.	2012	second_quarter	MED	Educated members of the House of Representatives on the importance of encouraging innovation in rare cancer drug development.	HOUSE OF REPRESENTATIVES	50000		0	0	2012-07-18T11:32:26.947000-04:00